We are delighted to announce that Hilaria Mollica, from our High Content Screening Unit, will be attending the upcoming Arturo Falaschi Conference “1st biennial conference on TDP-43 function and dysfunction in disease” in Trieste, organized by the International Centre for Genetic Engineering and Biotechnology (ICGEB).
At Axxam, we have made a significant investment towards advancing our understanding of the role of TDP43 in neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS) and Fronto-Temporal Dementia (FTLD), through developing in vitro assays suitable for high-throughput screening.
Hilaria will share some insights into our research with the following presentation “Addressing in vitro TDP43 pathology using high throughput assays”.